| Disease Specific Interactions between Host Protein and DME (HOSPPI) |
| ICD Disease Classification Healthy |
| ICD-11: Healthy |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Transcription-factor regulation |
| Transcription factor Sp1 (SP1) |
Health |
Activation |
| Uniprot ID |
|
| Interaction Name |
SP1-MAT2B interaction |
[1] |
| Studied Cell Lines |
Cos-1 and Jurkat human leukemic T cell lines |
| Ensembl ID |
|
| Description |
Transcription factor Sp1 (SP1) is reported to activate the transcription of MAT2B gene, which leads to an increased expression of the drug-metabolizing enzyme Methionine adenosyltransferase II beta. As a result, the interaction between SP1 and MAT2B can activate the drug-metabolizing process of Methionine adenosyltransferase II beta. |
| ICD Disease Classification 02 Neoplasms |
| ICD-11: 2C12 Liver cancer |
Click to Show/Hide the Full List of HOSPPI: 1 HOSPPI
|
| Non-coding RNA regulation |
| hsa-miR-21-3p |
Liver cancer |
Suppression |
| miRBase ID |
|
| Interaction Name |
hsa-miR-21-3p--MAT2B regulation |
[2] |
| Studied Cell Lines |
HepG2 cell line |
| Description |
hsa-miR-21-3p is reported to suppress MAT2B mRNA translation by binding to the 3' untranslated region (3'UTR) of MAT2B mRNA, which leads to a decreased expression of the drug-metabolizing enzyme Methionine adenosyltransferase II beta. |
|
|
|
|
|
|
